Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

United Kingdom

United Kingdom Articles

Companies

British Prime Minister Tony Blair has hinted that the government will not accept new value-based pricing proposals as laid out recently by the Office of Fair Trading (OFT). Speaking... 2007-03-20


Companies

According to a report from the Association of the British Pharmaceutical Industry, the availability of more effective drugs with fewer side effects, coupled with a better understanding... 2007-03-16


Companies

UK retailer Alliance Boots is reportedly the target of a GBP9.7bn (US$18.84bn) bid from deputy chairman Stefano Pessina, backed by private equity firm Kohlberg Kravis Roberts ... 2007-03-12


Companies

US-based drugmaker Pfizer has won a key decision in the UK allowing it to supply its product through a single wholesaler. The High Court in London refused to grant an injunction... 2007-03-06


Companies

UK-based drugmaker GlaxoSmithKline (GSK) has announced that it is experimental cancer drug Tykerb (lapatinib) will shortly enter advanced clinical trials for the treatment of tumours... 2007-03-01


Companies

UK-based drugmaker is to purchase US-based New River Pharmaceuticals, in a deal worth US$2.6bn as it attempts to consolidate its position in the lucrative attention-deficit hyperactivity... 2007-02-21


Companies

The drug industry in the UK could be impacted by a planned overhaul of the drug-pricing regime. The Office of Fair Trading (OFT) has recently conducted an inquiry into the pharmaceutical... 2007-02-19


Companies

UK-based retailer Boots is planning to sell anti-impotence drug Viagra (sildenafil) over-the-counter (OTC), and is currently piloting the scheme at three stores in Manchester. Presently,... 2007-02-12


Companies

This was not always so, and in 2001 GSK found itself in a similar position of uncertainty and responded with a series of job cuts. Since that time, though, the company has implemented... 2007-02-09


Companies

Following on from US drugmaker Pfizer's decision to cut 10,000 jobs, Anglo-Swedish drug firm AstraZeneca is slashing 5% of its workforce, as a wave of cost cutting hits the industry.... 2007-02-02

81 to 90 of 145 results
<< | < | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | > | >>
Insight